查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1530036

體內注射器市場規模、佔有率和趨勢分析報告：2024-2030 年按技術、應用、最終用途、地區和細分市場進行的預測

On-body Injectors Market Size, Share & Trends Analysis Report By Technology (Spring-based, Motor Driven), By Application (Oncology, Diabetes), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

體載注射器市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球體貼注射器市場規模預計將達到127億美元，2024年至2030年複合年成長率為14.9%。

體內注射器更易於使用、疼痛更少，並且允許在較長時間內給藥而無需頻繁去醫院，從而提高了患者的用藥依從性。這些優點使得體內注射器越來越受歡迎。此外，亞太地區等醫療基礎設施發達且先進醫療設備的採用不斷增加的地區在預測期內為市場成長提供了巨大的機會。

對針刺的日益關注以及需要透過消除與針頭插入、藥物製備、針頭覆蓋和處置相關的風險來提高患者和醫療保健專業人員的安全是預計癌症等慢性病患病率進一步增加的一些因素；推動預測期內的市場成長。

根據世界衛生組織國際癌症研究機構 (IARC) 的數據，到 2022 年，約有 2,000 萬人將被診斷出罹患癌症，約 970 萬人將死於癌症。有些癌症和其他慢性疾病的治療需要長期頻繁注射藥物。與傳統的醫院就診或自行注射相比，體內注射器為患者接受這些藥物提供了更方便且潛在破壞性更小的替代方案。

體載注射器市場報告亮點

  • 從技術上來看，彈簧式在2023年佔據最大的銷售佔有率，為40.89%，其穩定的壓力和速度保證了精確的計量。
  • 從技術角度來看，由於對劑量的更好控制、最大限度地減少用藥錯誤的風險以及最大限度地提高治療效果，旋轉泵預計在預測期內將以 15.1% 的複合年成長率快速成長。
  • 從應用來看，由於第2型糖尿病盛行率較高，需要頻繁給藥，糖尿病領域在2023年佔據了最大的銷售佔有率。
  • 從應用來看，由於多發性硬化症、類風濕性關節炎和發炎性腸道疾病（IBD）等慢性自體自體免疫疾病的盛行率不斷上升，預計自體免疫疾病領域將以最快的年複合成長率成長。
  • 根據最終用途，由於人們越來越偏好自行給藥來治療糖尿病、自體免疫疾病和癌症等慢性疾病，因此居家照護領域在 2023 年佔據了最大的收益佔有率。
  • 2023年，北美地區佔33.17%。這是由於主要市場參與者的存在、居家照護的增加以及先進的體內注射器的使用增加。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章 車用注射器市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 體載注射器市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 人體注射器市場：依技術估算與趨勢分析

  • 細分儀表板
  • 體用注射器市場：技術差異分析
  • 體上注射器市場：技術展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 彈簧底座
  • 馬達驅動
  • 旋轉泵
  • 擴充電池
  • 其他

第5章 體內注射器市場：依應用估算與趨勢分析

  • 細分儀表板
  • 體用注射器市場：依應用進行變化分析
  • 體上注射器市場：按應用分類的前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 腫瘤學
  • 糖尿病
  • 心血管疾病
  • 自體免疫疾病
  • 其他

第6章 體內注射器市場：依最終用途分類的估計與趨勢分析

  • 細分儀表板
  • 體用注射器市場：最終用途的變化分析
  • 體上注射器市場：依最終用途分類的前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 醫院/診所
  • 居家照護環境
  • 其他

第7章 體內注射器市場：區域估計與趨勢分析

  • 區域儀表板
  • 體載注射器市場：區域差異分析
  • 體用注射器市場：按技術、應用和最終用途進行區域估計和趨勢分析
  • 2018-2030年市場規模、預測及趨勢分析
  • 北美洲
    • 2018-2030年北美人體注射器市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030 年歐洲人體注射器市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030 年亞太地區體上注射器市場估計與預測
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲人體注射器市場估計與預測
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 2018-2030 年中東和非洲體內注射器市場估計和預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 市場參與企業分類
  • 主要企業簡介
    • West Pharmaceutical Services, Inc.
    • BD
    • Stevanato Group
    • Enable Injections
    • Nemera
    • Debiotech SA
    • AbbVie, Inc.
    • Coherus BioSciences, Inc.
    • Gerresheimer AG
    • E3D Elcam Drug Delivery Devices
Product Code: GVR-4-68040-395-4

On-body Injectors Market Growth & Trends:

The global on-body injectors market size is expected to reach USD 12.7 billion by 2030, registering a CAGR of 14.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The on-body injectors increase patient adherence to medication by offering easy-to-use, less pain and enabling extended drug administration without frequent hospital visits. These advantages of on-body injectors are significantly increasing their popularity. Moreover, regions such as Asia Pacific, with developing healthcare infrastructure and rising adoption of advanced medical devices, offer huge opportunities for market growth over the forecast period.

The increasing concerns over needle stick injuries and the need to increase the safety for both patients and healthcare professionals by eliminating risks associated with needle insertion, drug preparation, and covering & disposing of needles, coupled with the increasing prevalence of chronic diseases such as cancer are some of the factors expected to drive the market growth over the forecast period.

According to the WHO agency International Agency for Research on Cancer (IARC), around 20 million people were diagnosed with cancer, and around 9.7 million mortalities occurred due to cancer in 2022. Several cancers and other chronic disease treatments require frequent injections of medications over extended periods. On-body injectors offer a convenient and potentially less disruptive alternative for patients to receive these medications compared to traditional hospital visits or self-administered injections, which can significantly increase their demand over the forecast period.

On-body Injectors Market Report Highlights:

  • Based on the technology, the spring-based segment accounted for the largest revenue share of 40.89% in 2023 owing to their consistent pressure and speed, which ensures precise dosing
  • Based on technology, the rotary pump segment is expected to grow at the fastest CAGR of 15.1% during the forecast period owing to the high control offered by them in dispensing medications, minimizing the risk of dosing errors and maximizing therapeutic efficacy
  • Based on the application, the diabetes segment accounted for the largest revenue share in 2023 due to the high prevalence of type 2 diabetes, which requires frequent administration
  • Based on the application, the autoimmune diseases segment is expected to grow at the fastest CAGR owing to the rising prevalence of chronic autoimmune conditions such as multiple sclerosis, rheumatoid arthritis, and Inflammatory Bowel Diseases (IBD)
  • Based on the end use, the homecare segment accounted for the largest revenue share in 2023 owing to the growing preference for self-administration of medications for managing chronic conditions such as diabetes, autoimmune disorders, and cancer in homecare settings
  • In 2023, North America dominated with a share of 33.17%, driven by the presence of key market players, an increasing shift toward home care, and better access to advanced on-body injectors

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.1. Segment Definitions
    • 1.1.1. Technology
    • 1.1.2. Application
    • 1.1.3. End Use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecasts timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Application outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. On-body Injectors Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Patient preference and compliance
      • 3.2.1.4. Increasing focus on home healthcare
      • 3.2.1.5. Increasing concerns about needlestick injuries
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost compared to alternatives
  • 3.3. On-body Injectors Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. On-body Injectors Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. On-body Injectors Market: Technology Movement Analysis
  • 4.3. On-body Injectors Market by Technology Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Spring-based
    • 4.5.1. Spring-based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Motor-driven
    • 4.6.1. Motor-driven Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Rotary Pump
    • 4.7.1. Rotary Pump Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Expanding Battery
    • 4.8.1. Expanding Battery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Other
    • 4.9.1. Other Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. On-body Injectors Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. On-body Injectors Market: Application Movement Analysis
  • 5.3. On-body Injectors Market by Application Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Oncology
    • 5.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Diabetes
    • 5.6.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Cardiovascular Disease
    • 5.7.1. Cardiovascular Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Autoimmune Disease
    • 5.8.1. Autoimmune Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. On-body Injectors Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. On-body Injectors Market: End Use Movement Analysis
  • 6.3. On-body Injectors Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Hospitals & Clinics
    • 6.5.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Home Care Settings
    • 6.6.1. Home Care Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. On-body Injectors Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional On-body Injectors Market movement analysis
  • 7.3. On-body Injectors Market: Regional Estimates & Trend Analysis by Technology, Application & End Use
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. North America
    • 7.5.1. North America On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. UK
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. UK On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. Germany On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. France On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. Italy On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Spain On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Denmark
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Denmark On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Key Country Dynamics
      • 7.6.8.2. Competitive Scenario
      • 7.6.8.3. Regulatory Framework
      • 7.6.8.4. Reimbursement scenario
      • 7.6.8.5. Sweden On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.9. Norway
      • 7.6.9.1. Key Country Dynamics
      • 7.6.9.2. Competitive Scenario
      • 7.6.9.3. Regulatory Framework
      • 7.6.9.4. Reimbursement scenario
      • 7.6.9.5. Norway On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Asia Pacific On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Japan
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Japan On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. China
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. China On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. India
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. India On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. South Korea On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.6. Australia
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory Framework
      • 7.7.6.4. Reimbursement scenario
      • 7.7.6.5. Australia On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.7. Thailand
      • 7.7.7.1. Key Country Dynamics
      • 7.7.7.2. Competitive Scenario
      • 7.7.7.3. Regulatory Framework
      • 7.7.7.4. Reimbursement scenario
      • 7.7.7.5. Thailand On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Latin America On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. Brazil
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. Brazil On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Argentina On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9. Middle East & Africa
    • 7.9.1. Middle East & Africa On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.2. South Africa
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Competitive Scenario
      • 7.9.2.3. Regulatory Framework
      • 7.9.2.4. Reimbursement scenario
      • 7.9.2.5. South Africa On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.3. Saudi Arabia
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Competitive Scenario
      • 7.9.3.3. Regulatory Framework
      • 7.9.3.4. Reimbursement scenario
      • 7.9.3.5. Saudi Arabia On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.4. UAE
      • 7.9.4.1. Key Country Dynamics
      • 7.9.4.2. Competitive Scenario
      • 7.9.4.3. Regulatory Framework
      • 7.9.4.4. Reimbursement scenario
      • 7.9.4.5. UAE On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.5. Kuwait
      • 7.9.5.1. Key Country Dynamics
      • 7.9.5.2. Competitive Scenario
      • 7.9.5.3. Regulatory Framework
      • 7.9.5.4. Reimbursement scenario
      • 7.9.5.5. Kuwait On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. West Pharmaceutical Services, Inc.
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. BD
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Stevanato Group
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Enable Injections
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Nemera
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Debiotech SA
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. AbbVie, Inc.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Coherus BioSciences, Inc.
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Gerresheimer AG
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. E3D Elcam Drug Delivery Devices
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 4 Global on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America on-body injectors market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 8 North America on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 11 U.S. on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 14 Canada on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 17 Mexico on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe on-body injectors market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 21 Europe on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 23 UK on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 24 UK on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 25 UK on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Germany on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Germany on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 28 Germany on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 30 France on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 31 France on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Italy on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Spain on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Norway on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Norway on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 40 Norway on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 42 Sweden on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Denmark on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 45 Denmark on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 46 Denmark on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific on-body injectors market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Japan on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Japan on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 53 Japan on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 54 China on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 55 China on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 56 China on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 58 India on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 59 India on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Australia on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Australia on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 62 Australia on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 63 South Korea on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 64 South Korea on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 65 South Korea on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 67 Thailand on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America on-body injectors market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 71 Latin America on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Brazil on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 77 Argentina on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa on-body injectors market, by country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 83 South Africa on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 84 South Africa on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Africa on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 89 UAE on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 90 UAE on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 91 UAE on-body injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait on-body injectors market, by technology, 2018 - 2030 (USD Million)
  • Table 93 Kuwait on-body injectors market, by application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait on-body injectors market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 On-body injectors market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 On-body injectors market, technology outlook key takeaways (USD Million)
  • Fig. 12 On-body injectors market: Technology movement analysis (USD Million), 2023 & 2030
  • Fig. 13 Spring-based market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Motor-driven market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Rotary pump market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Expanding battery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Other market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 On-body injectors market, application outlook key takeaways (USD Million)
  • Fig. 19 On-body injectors market: Application movement analysis (USD Million), 2023 & 2030
  • Fig. 20 Oncology market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Diabetes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Cardiovascular disease market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Autoimmune disease market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 On-body injectors market, end use outlook key takeaways (USD Million)
  • Fig. 26 On-body injectors market: End use movement analysis (USD Million), 2023 & 2030
  • Fig. 27 Hospitals & clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Home care settings market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 On-body injectors market: Regional key takeaways (USD Million)
  • Fig. 31 On-body injectors market: Regional outlook, 2023 & 2030, USD Million
  • Fig. 32 North America on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Canada on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Europe on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 UK on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Germany on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 France on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Spain on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Italy on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Norway on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Denmark on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 China on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Japan on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 India on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Australia on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 UAE on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 List of key emerging company's/technology disruptors/innovators